Skip to main content

Peer Review reports

From: Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy regimens: a subgroup analysis from a randomized clinical trial of response in subjects by cancer type

Original Submission
22 Aug 2019 Submitted Original manuscript
1 Dec 2019 Reviewed Reviewer Report - Joseph S. Bubalo
3 Dec 2019 Reviewed Reviewer Report - Hironobu Hashimoto
23 Mar 2020 Reviewed Reviewer Report - Research Square Reviewer 1
15 Jun 2020 Author responded Author comments - Cindy Weinstein
Resubmission - Version 2
15 Jun 2020 Submitted Manuscript version 2
22 Jul 2020 Author responded Author comments - Cindy Weinstein
Resubmission - Version 3
22 Jul 2020 Submitted Manuscript version 3
3 Aug 2020 Author responded Author comments - Cindy Weinstein
Resubmission - Version 4
3 Aug 2020 Submitted Manuscript version 4
Publishing
4 Aug 2020 Editorially accepted
25 Sep 2020 Article published 10.1186/s12885-020-07259-5

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us